Company intelligence / Profile preview
Sonata Therapeutics
Watertown, Massachusetts, United Statessonatatx.com ↗
- Ownership
- Private
- Employees
- ~60
- Development stage
- Preclinical
01
Overview
The company was developing therapeutics that transform diseased cells into coordinators of cure, with a focus on reprogramming cancer cells to release curative signals that reverse immune cell suppression. However, the company is no longer operating.
- Therapeutic areas
- OncologyPulmonologyImmunology
- Modalities
- Small molecule drugsgenetic therapeutics
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Flagship Pioneering
Beyond the preview
Go deeper on Sonata Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sonata Therapeutics.